News | Cardiac Imaging | August 18, 2017

ASNC and SNMMI Release Joint Document on Diagnosis, Treatment of Cardiac Sarcoidosis

Document crafted by multidisciplinary team of experts focuses on role of 18F-FDG PET/CT

ASNC and SNMMI Release Joint Document on Diagnosis, Treatment of Cardiac Sarcoidosis

August 18, 2017 — The American Society of Nuclear Cardiology (ASNC) has released a joint expert consensus document with the Society of Nuclear Medicine and Molecular Imaging (SNMMI) on the role of 18F-FDG positron emission tomography/computed tomography (PET/CT) in cardiac sarcoid detection and therapy monitoring.

The recognition that randomized prospective trials are not available for this rare disease and are unlikely to be conducted has prompted the Cardiovascular Council of the SNMMI and the ASNC to assemble a multidisciplinary team of experts not only in imaging but also in clinical cardiology, cardiac electrophysiology, heart failure, and systemic sarcoidosis to develop this comprehensive consensus statement. 

The full document can be read here.

For more information: www.asnc.org, www.snmmi.org

Related Content

Toshiba Showcases MRI Workflow Enhancements at RSNA 2017
News | Magnetic Resonance Imaging (MRI) | September 21, 2017
September 21, 2017 — Toshiba Medical will highlight its latest...
News | Business | September 19, 2017
September 19, 2017 — Invicro LLC, a provider of imaging services and software for research and drug development, anno
ScImage and Invia Partnership Announced
News | PACS | September 19, 2017
ScImage Inc. and Invia Imaging Solutions recently announced formation of a joint partnership at the American Society of...
Toshiba Highlights Latest CT Advancements at RSNA 2017
News | Computed Tomography (CT) | September 18, 2017
Toshiba Medical announced that it will display several new enhancements to its existing computed tomography (CT)...
Philips Launches CardioMD IV Cardiac SPECT Solution at ASNC 2017
Technology | SPECT Imaging | September 15, 2017
September 15, 2017 — Philips highlighted its newest solution for...
Double Targeting Ligands to Identify and Treat Prostate Cancer

The mice were imaged with small-animal PET/CT using 124I-RPS-027 (7.4 MBq [200 μCi]). Credit: JM Kelly et al., Department of Radiology, Weill Cornell Medicine, New York, NY

News | Prostate Cancer | September 14, 2017
Researchers have demonstrated a new, effective way to precisely identify and localize prostate cancer tumors while...
Mississippi Surgical and Vascular Center Uses Toshiba Ultimax-I FPD to Save Patients' Limbs
News | Angiography | September 14, 2017
The southern U.S. sees some of the highest numbers of chronic medical conditions, such as peripheral artery disease...
Philips Showcases Integrated Vascular Solutions at VIVA 2017
News | Cardiac Imaging | September 13, 2017
Philips announced its presence at the Vascular Interventional Advances (VIVA 17) Annual Conference in Las Vegas from...
Blue Earth Diagnostics Announcing Results of FALCON PET/CT Trial at ASTRO 2017
News | PET-CT | September 13, 2017
September 13, 2017 — Blue Earth Diagnostics announced the upcoming oral presentation of initial results from the FALC
Orange County, Calif. Hospital Adopts Siemens Somatom Force CT for Cardiac Imaging
News | Computed Tomography (CT) | September 12, 2017
Hoag Memorial Hospital Presbyterian recently became the first hospital in Orange County, Calif., to install the Siemens...
Overlay Init